Stay informed about the metformin extended release 500 mg recall and take necessary precautions to ensure your health and safety. Get the latest updates and information about the recall to make informed decisions about your medication.

Payment:	VISA, MasterCard, Amex, PayPal
Delivery:	Express (1-3 days), AirMail FREE (5-7 days)
Prescription:	OVER THE COUNTER
Where to Buy OTC drugs overnight?	https://pharma4health.com

Metformin extended release 500 mg recall

Metformin Extended Release 500 mg is a commonly prescribed medication used to manage and control blood sugar levels in individuals with type 2 diabetes. However, recently there has been a recall of specific batches of this medication due to potential contamination concerns.

The recall was initiated by the pharmaceutical company after it was discovered that certain batches of Metformin Extended Release 500 mg may contain higher than allowable levels of a compound called N-Nitrosodimethylamine (NDMA). NDMA is classified as a probable human carcinogen, meaning it has the potential to cause cancer in humans if consumed at high levels over a long period of time.

Patients who have been prescribed Metformin Extended Release 500 mg are advised to check the batch number and expiration date on their medication bottles and consult with their healthcare provider if they have any of the affected batches. It is important to note that not all batches of the medication are affected, and alternative formulations or dosages of Metformin may be available.

In the meantime, the FDA has recommended that patients continue taking their medication unless specifically instructed otherwise by their healthcare provider. It is important to maintain glycemic control and manage blood sugar levels to prevent complications associated with uncontrolled diabetes.

Metformin Extended Release 500 mg Recall

Recently, there has been a recall of Metformin Extended Release 500 mg tablets due to potential contamination concerns. This recall has raised concerns among patients who rely on this medication to manage their diabetes.

Reason for Recall

The recall was initiated by the manufacturer after testing revealed the presence of a probable human carcinogen called N-Nitrosodimethylamine (NDMA) in certain batches of Metformin Extended Release 500 mg tablets. NDMA is a substance that can potentially cause cancer in humans if consumed in large amounts over a long period of time.

Impact on Patients

Patients who have been prescribed Metformin Extended Release 500 mg tablets are advised to check the lot number and expiration date on their prescription bottle to determine if their medication is affected by the recall. If their medication is included in the recall, patients should contact their healthcare provider or pharmacist for guidance on how to proceed.

It is important for patients to continue taking their prescribed medication until they can obtain a replacement. Suddenly stopping the medication without an alternative can have negative effects on their diabetes management.

Next Steps for Patients

If a patient’s medication is affected by the recall, they should reach out to their healthcare provider or pharmacist to discuss alternative treatment options. It is crucial for patients to continue their diabetes management plan to prevent any negative health consequences.

Patients should also stay updated on any developments related to the recall by regularly checking the manufacturer’s website or news sources. It is important to keep informed about any new information or instructions regarding the recall.

Conclusion

The recall of Metformin Extended Release 500 mg tablets due to potential contamination concerns has raised concerns among patients who rely on this medication to manage their diabetes. Patients are advised to check if their medication is included in the recall and to seek guidance from their healthcare provider or pharmacist. It is crucial for patients to continue their diabetes management plan and stay informed about any new developments related to the recall.

Reasons for the Recall

There are several reasons for the recall of metformin extended release 500 mg tablets. These reasons include:

Presence of N-Nitrosodimethylamine (NDMA): The recall is due to the potential presence of NDMA, which is classified as a probable human carcinogen. NDMA is a substance that can be found in certain foods, water, air pollution, and industrial processes. It is also a known contaminant in certain medications.
Elevated levels of NDMA: The recalled metformin extended release tablets have been found to contain levels of NDMA above the acceptable limits set by the U.S. Food and Drug Administration (FDA). NDMA levels above the acceptable daily intake limit may increase the risk of cancer.
Long-term exposure to NDMA: Prolonged exposure to NDMA, even at low levels, may increase the risk of developing cancer. The recall is a precautionary measure to ensure the safety of the patients who have been prescribed metformin extended release 500 mg tablets.
Quality control issues: The recall may also be a result of quality control issues during the manufacturing process. The presence of NDMA in medications is not intentional but may occur due to the manufacturing process or the sourcing of raw materials.

It is important for patients who have been prescribed metformin extended release 500 mg tablets to consult their healthcare providers and seek alternative medications if necessary. The recall is being conducted to protect patient health and ensure the safety of medications on the market.

SHOCKING SECRETS BIG PHARMA DOESN’T WANT YOU TO KNOW ABOUT OTC DRUGS:

SURPRISING FACTS AND COMMON MYTHS BUSTED IN OUR OTC DRUGS FAQ:

What is Metformin extended release 500 mg recall?

Metformin extended release 500 mg recall is a recall of a specific medication called Metformin extended release 500 mg. The recall is due to potential contamination with a substance called N-nitrosodimethylamine (NDMA), which is classified as a probable human carcinogen.

Why is Metformin extended release 500 mg being recalled?

Metformin extended release 500 mg is being recalled due to potential contamination with N-nitrosodimethylamine (NDMA). NDMA is a substance that is classified as a probable human carcinogen, meaning it has the potential to cause cancer in humans.

What are the potential risks associated with taking Metformin extended release 500 mg?

The potential risks associated with taking Metformin extended release 500 mg include exposure to a probable human carcinogen called N-nitrosodimethylamine (NDMA), which has the potential to cause cancer in humans. Long-term exposure to NDMA may increase the risk of certain types of cancer, such as liver cancer.

Has anyone reported any adverse effects from taking Metformin extended release 500 mg?

There have been reports of adverse effects from taking Metformin extended release 500 mg, but it is important to note that not all individuals who take the medication will experience these effects. The reported adverse effects include nausea, vomiting, stomach pain, diarrhea, and dizziness.

What should I do if I have been taking Metformin extended release 500 mg?

If you have been taking Metformin extended release 500 mg, you should contact your healthcare provider to discuss the recall and determine the best course of action. Your healthcare provider may recommend switching to a different medication or adjusting your treatment plan.

Is there a replacement medication available for Metformin extended release 500 mg?

Yes, there are alternative medications available for Metformin extended release 500 mg. Your healthcare provider can recommend a suitable replacement based on your individual needs and medical history. It is important to consult with your healthcare provider before making any changes to your medication regimen.